Show Summary Details
Page of

Chromophobe renal cell carcinoma in an adult 

Chromophobe renal cell carcinoma in an adult
Chromophobe renal cell carcinoma in an adult

Federica Recine

and Cora Sternberg

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 January 2021

Renal cell carcinoma (RCC) is the most common neoplasm of the kidney. Clear cell carcinoma is the most common subtype of RCC (80%) and approximately 10% of renal cell carcinomas are is chromophobe subtype. Surgery is the standard treatment of localised RCC. The systemic treatment of advanced clear cell renal cell carcinoma is based on inhibitors of VEGF and mTOR pathways. However, the clinical efficacy of these agents in non-clear cell RCC remains unclear.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.